# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-26-335103
Filing Date
2026-08-05
Accepted
2026-08-05 16:10:48
Documents
77
Period of Report
2026-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | lab-20260630.htm iXBRL | 10-Q | 3046929
2 | EX-31.1 | lab-ex31_1.htm | EX-31.1 | 18003
3 | EX-31.2 | lab-ex31_2.htm | EX-31.2 | 19065
4 | EX-32.1 | lab-ex32_1.htm | EX-32.1 | 10403
5 | EX-32.2 | lab-ex32_2.htm | EX-32.2 | 10371
6 | GRAPHIC | img243432088_0.jpg | GRAPHIC | 182351
| Complete submission text file | 0001193125-26-335103.txt |  | 11933385

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | lab-20260630.xsd | EX-101.SCH | 1448767
81 | EXTRACTED XBRL INSTANCE DOCUMENT | lab-20260630_htm.xml | XML | 2102638

Mailing Address 50 MILK STREET 10TH FLOOR BOSTON MA 02109
Business Address 50 MILK STREET 10TH FLOOR BOSTON MA 02109 6502666000
STANDARD BIOTOOLS INC. (Filer) CIK: 0001162194 (see all company filings)

EIN.: 770513190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34180 | Film No.: 261243596
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)